This website uses cookies

Cookies are small text files that can be used by websites to make a user's experience more secure and to analyze traffic to the site. We use cookies for the following purposes:

- Necessary: Cookies are required to access secure areas of the website and to provide important platform notifications. The site cannot function properly without these cookies
- Statistics: Cookies are used to track device information anonymously to better understand how visitors interact with the website.

This notice applies to the following domains: goto.webcasts.com

Uncleared Margin Rules: How to Comply in Time & Within Budget

The  webinar recording is available. If already registered, please enter  your email address into the field at the top right corner for immediate  access to the recording. If you haven’t registered already you must do  so below before viewing the video.
A live Webcast April 3rd at 9.30am NY / 2.30pm UK

 
Join us to explore strategies for how category 4/ 5 firms can meet upcoming UMR requirements on time and within budget using established industry resources.
 
As the OTC derivatives industry ramps up for the final two deadlines to comply with uncleared margin requirements (UMR) as per the BCBS/IOSCO framework, the firms that fall into scope for phases 4 and 5 face a steep learning curve ahead of their respective 2019 and 2020 deadlines. Phase 5 in particular, captures a wide net of entities as it applies to firms with  that have an Average Aggregated Notional Amount (AANA) of $8 billion whereas Phase 4 targets a smaller net as it captures entities with an AANA of $750 billion or more.
 
In this webinar, a panel will offer an update on the current status of the UMR rules and how recent changes impact Phase 4 and 5 firms and the derivatives industry. The panel will explore the structure of a UMR implementation plan that supports phase 4 and 5 firms’ specific needs and enables these firms to comply with the margin rules in both a timely and cost-effective manner through the use of established industry resources, including AcadiaSoft. Attendees will hear more about suggested project planning timelines and other tips for compliance from industry experts. Join this webinar to gain more insight on the following: 

•   UMR status quo – what has been the result of recent advocacy changes and what does this mean to firms?
•   Implementation plan – what does a UMR compliance plan look like for a phase 4 or 5 firm? How might this differ from phase 1 and 2 firms?
•   Timing & costs – what is a feasible timeline from project inception to completion? How can a firm reduce costs?
•   Industry resources – how AcadiaSoft brings together its experience, experts and risk services suite to assist firms in their compliance efforts
•   Lessons learned – what lessons can phase 4 and 5 firms learn from previous phases?

Panel:
  • Yaron Katz, Global Head of Risk Operations at Coremont, a provider of collateral services to Brevan Howard
  • John Pucciarelli, Director of Strategic Initiatives, AcadiaSoft
  • Allen Lewis, Managing Director, BNY Mellon Markets
  • Moderator: Julia Schieffer, DerivSource.com
  • *** More speakers announced shortly!
Please note: This webinar is for general information only. It is not a full analysis of the matters presented and should not be relied upon as legal or investment advice. Please also refer to the DerivSource.com’s terms of use and privacy policy for more information about our webinars and attendance.
Already Registered? Log In Now

Complete this form to enter the webcast.
(* indicates required field)

  • Yes 2019
  • Yes 2020
  • No
  • Not sure